• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床生物化学监测

Monitoring in clinical biochemistry.

作者信息

Doust Jenny, Glasziou Paul

机构信息

Centre for Research in Evidence Based Practice, Bond University, Robina, Qld 4429, Australia.

出版信息

Clin Biochem Rev. 2013 Aug;34(2):85-92.

PMID:24151344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3799222/
Abstract

Monitoring tests form an increasing proportion of the workload in clinical biochemistry and biochemists can help by providing clinicians with information about the variability and precision of tests, the time frame for pharmacodynamic stabilisation after a treatment change, and the frequency of testing. This paper outlines the phases of monitoring, and how to decide if monitoring is beneficial, which test to use for monitoring, when a change in the test result indicates a need for the change in treatment and the length of testing intervals. We conclude with some recommendations for biochemists for future areas of research and advice that can be given to clinicians.

摘要

监测测试在临床生物化学工作量中所占比例日益增加,生物化学家可以通过向临床医生提供有关测试的变异性和精密度、治疗改变后药效学稳定的时间框架以及测试频率等信息来提供帮助。本文概述了监测的各个阶段,以及如何确定监测是否有益、用于监测的测试方法、测试结果的变化何时表明需要改变治疗以及测试间隔的时长。我们最后为生物化学家提出了一些关于未来研究领域的建议,以及可以提供给临床医生的建议。

相似文献

1
Monitoring in clinical biochemistry.临床生物化学监测
Clin Biochem Rev. 2013 Aug;34(2):85-92.
2
A web-based clinical decision support system for gestational diabetes: Automatic diet prescription and detection of insulin needs.一种用于妊娠期糖尿病的基于网络的临床决策支持系统:自动饮食处方及胰岛素需求检测
Int J Med Inform. 2017 Jun;102:35-49. doi: 10.1016/j.ijmedinf.2017.02.014. Epub 2017 Mar 6.
3
4
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Medical Biochemistry as Subdiscipline of Laboratory Medicine in Serbia.医学化学作为塞尔维亚检验医学的一个子学科。
J Med Biochem. 2017 Apr 22;36(2):177-186. doi: 10.1515/jomb-2017-0010. eCollection 2017 Apr.
7
Internet resources and biochemistry.互联网资源与生物化学
Indian J Clin Biochem. 2006 Mar;21(1):137-41. doi: 10.1007/BF02913082.
8
Clinical importance of the intervertebral disc, or back pain for biochemists.椎间盘的临床重要性,或生物化学家眼中的背痛。
Biochem Soc Trans. 2002 Nov;30(Pt 6):829-31. doi: 10.1042/bst0300829.
9
Education in Medical Biochemistry in Serbia.塞尔维亚的医学生物化学教育。
EJIFCC. 2010 Jun 9;21(2):49-52. eCollection 2010 Jun.
10

引用本文的文献

1
Towards the development of cost-effective point-of-care diagnostic tools for poverty-related infectious diseases in sub-Saharan Africa.面向撒哈拉以南非洲与贫困相关传染病的具有成本效益的即时诊断工具的开发。
PeerJ. 2024 Jun 21;12:e17198. doi: 10.7717/peerj.17198. eCollection 2024.
2
Evidence-based laboratory medicine.循证检验医学
Clin Biochem Rev. 2013 Aug;34(2):43-6.

本文引用的文献

1
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations.慢性肾脏病及估算肾小球滤过率自动报告:新进展与修订建议。
Med J Aust. 2012 Aug 20;197(4):224-5. doi: 10.5694/mja11.11329.
2
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).比较两种基于遗传药理学算法和标准护理的华法林个体化剂量方案的随机、临床有效性试验(CoumaGen-II)。
Circulation. 2012 Apr 24;125(16):1997-2005. doi: 10.1161/CIRCULATIONAHA.111.070920. Epub 2012 Mar 19.
3
Interpretation and management of INR results: a case history based survey in 13 countries.INR 结果解读和处理:13 个国家基于病例的调查。
Thromb Res. 2012 Sep;130(3):309-15. doi: 10.1016/j.thromres.2012.02.014. Epub 2012 Mar 16.
4
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.未使用胰岛素的2型糖尿病患者的血糖自我监测
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD005060. doi: 10.1002/14651858.CD005060.pub3.
5
How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data.我们应该多快调整降压药物的剂量?来自试验数据的系统评价模型血压反应。
Heart. 2011 Nov;97(21):1771-5. doi: 10.1136/hrt.2010.221473. Epub 2011 May 17.
6
Cardiovascular risk scores do not account for the effect of treatment: a review.心血管风险评分不能解释治疗效果:综述。
Heart. 2011 May;97(9):689-97. doi: 10.1136/hrt.2010.220442.
7
The rise of cholesterol testing: how much is unnecessary.胆固醇检测的兴起:有多少是不必要的。
Br J Gen Pract. 2011 Feb;61(583):e81-8. doi: 10.3399/bjgp11X556245.
8
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.更强化降低 LDL 胆固醇的疗效和安全性:来自 26 项随机试验中 170000 名参与者数据的荟萃分析。
Lancet. 2010 Nov 13;376(9753):1670-81. doi: 10.1016/S0140-6736(10)61350-5. Epub 2010 Nov 8.
9
A1C to detect diabetes in healthy adults: when should we recheck?A1C 用于检测健康成年人的糖尿病:我们何时应再次检查?
Diabetes Care. 2010 Sep;33(9):2016-7. doi: 10.2337/dc10-0588. Epub 2010 Jun 21.
10
Lipid re-screening: what is the best measure and interval?血脂再筛查:最佳检测指标和间隔时间是什么?
Heart. 2010 Mar;96(6):448-52. doi: 10.1136/hrt.2009.172619. Epub 2009 Jun 14.